JONATHAN CAGLE: Open Payments
NPI 1659963882 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 21 payments from 9 companies in 2025. Trend: 2023 $374 · 2024 $446 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $165 |
| Lundbeck LLC | 4 | $73 |
| Lilly USA, LLC | 4 | $71 |
| ABBVIE INC. | 3 | $54 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Corium, LLC | 2 | $41 |
| CSL Behring | 1 | $23 |
| Indivior Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: AIRSUPRA, MOUNJARO, REXULTI, VRAYLAR, Auvelity, Azstarys, Andembry, VYEPTI.
Industry payments across LA — which companies pay providers there.
